title: Is stunning an important component of preconditioning?
abstract: We tested the hypothesis that stunning following a brief period of ischaemia is a component of cardioprotection afforded by preconditioning in an in vitro model of global normothermic ischaemia. Isolated Langendorff-perfused rat hearts, after 120-150 min of aerobic perfusion, were divided into four groups. Groups 1 and 2 constituted the aerobic and ischaemic controls. The other hearts were preconditioned by two 2-min ischaemia/reperfusion cycles. Two ischaemic preconditioning protocols were used, the only difference being prolongation of the reperfusion cycle from 5 (group 3) to 20 min (group 4) before the onset of severe ischaemic insult. Mechanical function, energetic metabolism and the rate of enzyme release were followed throughout. In group 3, myocardial function remained significantly downregulated before the onset of severe ischaemia. This resulted in cardiac protection as evidenced by enhanced recovery of systolic pressure (37.7 +/- 3.6 v 61.9 +/- 5.7 mmHg for groups 2 and 3, respectively; P < 0.02), reduced rise in diastolic pressure (55.8 +/- 5.9 v 34.3 +/- 5.2 mmHg; P < 0.02), reduced creatine kinase (CK) release (957.3 +/- 175.7 v 541.5 +/- 85.9 mU/min/gww; P < 0.05) and higher contents of high-energy phosphate at the end of ischaemia [3.6 +/- 0.3 v 25.3 +/- 2.9 mumol/gdw for creatine phosphate (CP), P < 0.001] as well as after reperfusion (16.8 +/- 2.4 v 31.4 +/- 1.8 for CP, P < 0.01, and 3.9 +/- 0.5 v 6.2 +/- 0.8 mumol/gdw for ATP, P < 0.05). When severe ischaemia was started only after complete recovery of mechanical function (group 4), no protection was observed. Our data suggest that a decrease in mechanical function or stunning occurring after the short period of ischaemia causes ATP sparing and constitutes an additional mechanism of preconditioning cardioprotection in vitro.
authors.affiliation: Salvatore Maugeri Foundation, IRCCS, Cardiovascular Pathophysiology Research Center, Gussago, Brescia, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Cargnoni
authors.forename: C
authors.initials: C
authors.lastname: Ceconi
authors.forename: P
authors.initials: P
authors.lastname: Bernocchi
authors.forename: E
authors.initials: E
authors.lastname: Pasini
authors.forename: S
authors.initials: S
authors.lastname: Curello
authors.forename: R
authors.initials: R
authors.lastname: Ferrari
mesh_terms: D000818:Animals; D003402:Creatine Kinase / Q000378:metabolism; D006321:Heart / Q000502:physiology*; D019157:Ischemic Preconditioning, Myocardial; D008297:Male; D017682:Myocardial Stunning; D009206:Myocardium / Q000378:metabolism*; D010710:Phosphates / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D010710:Phosphates; D003402:Creatine Kinase